Profil
Shermaine Tilley is currently a Director at Xagenic, Inc., CellAegis Devices, Inc., Phemi Systems Corp., Rotman School of Management, CTI Capital, Inc., CFA Society Toronto, and CTI Life Sciences Fund LP.
He previously worked as a Director at Zymeworks BC, Inc., NeurAxon, Inc., BIOTECanada, Public Health Research Institute Center, and Chlorion Pharma, Inc. He was also a Senior Vice President at DRI Capital, Inc. and a Principal at New York University School of Medicine.
Tilley holds an MBA from the University of Toronto and a doctorate from The Johns Hopkins University School of Medicine.
Postes actifs de Shermaine Tilley
| Sociétés | Poste | Début |
|---|---|---|
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Develops automated molecular diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories | Directeur/Membre du Conseil | 01/01/2012 |
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2002 |
CTI Life Sciences Fund LP
CTI Life Sciences Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01/08/2006 |
CFA Society Toronto
CFA Society Toronto Miscellaneous Commercial ServicesCommercial Services Operates as a not-for-profit organization affiliated with CFA institute | Corporate Officer/Principal | - |
Phemi Systems Corp.
Phemi Systems Corp. Data Processing ServicesTechnology Services Operates as a big data warehouse company | Directeur/Membre du Conseil | 01/06/2015 |
CTI Capital, Inc.
CTI Capital, Inc. Investment ManagersFinance CTI Capital Inc. offers debt and equity trading, portfolio management, research, retail brokerage and investment banking services. They specialize in initial public offerings and new issues, private placements, reverse takeovers, capital pool companies, mergers and acquisitions and exchange sponsorships for emerging growth-oriented companies. The firm's equity research focuses on continuous global monitoring of the Canadian stock market. Their strategies are based on the evaluation of economic, financial and technical data. The firm employs market call systems that are based on fundamental and technical factors. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. The CTI Sciences Fund is a venture capital fund that invests primarily in companies located in Quebec and Canada. The Fund focuses on investments in biotechnological or biopharmaceutical products and medical devices. The financial partners of this private venture are the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, FIER Partenaires S.E.C. and the Régime des rentes du Mouvement Desjardins. | Private Equity Investor | - |
CellAegis Devices, Inc.
CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops device for the treatment of cardiac patients | Directeur/Membre du Conseil | - |
Anciens postes connus de Shermaine Tilley
| Sociétés | Poste | Fin |
|---|---|---|
| IMV INC. | Directeur/Membre du Conseil | 27/03/2023 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Directeur/Membre du Conseil | 10/05/2017 |
| ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░ ░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Shermaine Tilley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Finance |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CTI Capital, Inc.
CTI Capital, Inc. Investment ManagersFinance CTI Capital Inc. offers debt and equity trading, portfolio management, research, retail brokerage and investment banking services. They specialize in initial public offerings and new issues, private placements, reverse takeovers, capital pool companies, mergers and acquisitions and exchange sponsorships for emerging growth-oriented companies. The firm's equity research focuses on continuous global monitoring of the Canadian stock market. Their strategies are based on the evaluation of economic, financial and technical data. The firm employs market call systems that are based on fundamental and technical factors. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. The CTI Sciences Fund is a venture capital fund that invests primarily in companies located in Quebec and Canada. The Fund focuses on investments in biotechnological or biopharmaceutical products and medical devices. The financial partners of this private venture are the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, FIER Partenaires S.E.C. and the Régime des rentes du Mouvement Desjardins. | Finance |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CFA Society Toronto
CFA Society Toronto Miscellaneous Commercial ServicesCommercial Services Operates as a not-for-profit organization affiliated with CFA institute | Commercial Services |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
CTI Life Sciences Fund LP
CTI Life Sciences Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Public Health Research Institute Center
Public Health Research Institute Center Medical/Nursing ServicesHealth Services Provides biomedical research | Health Services |
Chlorion Pharma, Inc.
Chlorion Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule leads for the treatment of naturopathic pain and epilepsy | Commercial Services |
IMV, Inc.
IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Develops automated molecular diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories | Health Technology |
CellAegis Devices, Inc.
CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops device for the treatment of cardiac patients | Electronic Technology |
Phemi Systems Corp.
Phemi Systems Corp. Data Processing ServicesTechnology Services Operates as a big data warehouse company | Technology Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















